Prion-like disorders: Blurring the divide between transmissibility and infectivity

Journal of Cell Science

Volumn 123, Issue 8, 2010, Pages 1191-1201

  Cushman, Mimi ^a   Johnson, Brian S ^a   King, Oliver D ^b   Gitler, Aaron D ^a   Shorter, James ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b BOSTON BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

Amyloid; Infectivity; Prion; Stem cell; Therapy; Transmissibility

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID; AMYLOID BETA PROTEIN; BETA SECRETASE; POLYGLUTAMINE; POLYPEPTIDE; RNA BINDING PROTEIN; RNA BINDING PROTEIN TDP 43; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYLOIDOSIS; AMYOTROPHIC LATERAL SCLEROSIS; CELL INTERACTION; CYTOPLASM; DEGENERATIVE DISEASE; HUMAN; HUNTINGTON CHOREA; NERVE GRAFT; NONHUMAN; NOTE; PARKINSON DISEASE; PHENOTYPE; PRION; PRION DISEASE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

ALPHA-SYNUCLEIN; AMYLOID BETA-PROTEIN; ANIMALS; HUMANS; NEURONS; PEPTIDES; PRION DISEASES; PRIONS; STEM CELL TRANSPLANTATION; TAU PROTEINS;

MAMMALIAN PRION;

EID: 77951183978     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.051672     Document Type: Note

References (180)

1. Aguzzi, A. (2009). Cell biology: beyond the prion principle. Nature 459, 924-925.
2. Aguzzi, A. and Rajendran, L. (2009). The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron 64, 783-790.
3. Alberti, S., Halfmann, R., King, O., Kapila, A. and Lindquist, S. (2009). A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell 137, 146-158.
4. Alper, T., Cramp, W. A., Haig, D. A. and Clarke, M. C. (1967). Does the agent of scrapie replicate without nucleic acid? Nature 214, 764-766.
5. Auluck, P. K., Chan, H. Y., Trojanowski, J. Q., Lee, V. M. and Bonini, N. M. (2002). Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 295, 865-868. (Pubitemid 34118369)
6. Balducci, C., Beeg, M., Stravalaci, M., Bastone, A., Sclip, A., Biasini, E., Tapella, L., Colombo, L., Manzoni, C., Borsello, T. et al. (2010). Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein. Proc. Natl. Acad. Sci. USA 107, 2295-2300.
7. Barmada, S. J., Skibinski, G., Korb, E., Rao, E. J., Wu, J. Y. and Finkbeiner, S. (2010). Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J. Neurosci. 30, 639-649.
8. Baxa, U., Speransky, V., Steven, A. C. and Wickner, R. B. (2002). Mechanism of inactivation on prion conversion of the Saccharomyces cerevisiae Ure2 protein. Proc. Natl. Acad. Sci. USA 99, 5253-5260. (Pubitemid 34411535)
9. Beekes, M. and McBride, P. A. (2007). The spread of prions through the body in naturally acquired transmissible spongiform encephalopathies. FEBS J. 274, 588-605. (Pubitemid 46150854)
10. Belting, M. and Wittrup, A. (2008). Nanotubes, exosomes, and nucleic acid-binding peptides provide novel mechanisms of intercellular communication in eukaryotic cells: implications in health and disease. J. Cell Biol. 183, 1187-1191.
11. Bolton, D. C., McKinley, M. P. and Prusiner, S. B. (1982). Identification of a protein that purifies with the scrapie prion. Science 218, 1309-1311.
12. Braak, H. and Braak, E. (1997). Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging 18, 351-357. (Pubitemid 27435070)
13. Braak, H. and Del Tredici, K. (2008). Nervous system pathology in sporadic Parkinson disease. Neurology 70, 1916-1925.
14. Braak, H., Del Tredici, K., Rub, U., de Vos, R. A., Jansen Steur, E. N. and Braak, E. (2003). Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24, 197-211. (Pubitemid 36007810)
15. Brachmann, A., Baxa, U. and Wickner, R. B. (2005). Prion generation in vitro: amyloid of Ure2p is infectious. EMBO J. 24, 3082-3092.
16. Brandner, S., Isenmann, S., Raeber, A., Fischer, M., Sailer, A., Kobayashi, Y., Marino, S., Weissmann, C. and Aguzzi, A. (1996). Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379, 339-343.
17. Bremer, J., Baumann, F., Tiberi, C., Wessig, C., Fischer, H., Schwarz, P., Steele, A. D., Toyka, K. V., Nave, K. A., Weis, J. et al. (2010). Axonal prion protein is required for peripheral myelin maintenance. Nat. Neurosci. 13, 310-318.
18. Brown, J. C. and Lindquist, S. (2009). A heritable switch in carbon source utilization driven by an unusual yeast prion. Genes Dev. 23, 2320-2332.
19. Bruce, M. E. and Dickinson, A. G. (1987). Biological evidence that scrapie agent has an independent genome. J. Gen. Virol. 68, 79-89.
20. Brunden, K. R., Trojanowski, J. Q. and Lee, V. M. (2009). Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies. Nat. Rev. Drug Discov. 8, 783-793.
21. Brundin, P., Li, J. Y., Holton, J. L., Lindvall, O. and Revesz, T. (2008). Research in motion: the enigma of Parkinson's disease pathology spread. Nat. Rev. Neurosci. 9, 741-745.
22. Bueler, H., Aguzzi, A., Sailer, A., Greiner, R. A., Autenried, P., Aguet, M. and Weissmann, C. (1993). Mice devoid of PrP are resistant to scrapie. Cell 73, 1339-1347.
23. Castilla, J., Saa, P., Hetz, C. and Soto, C. (2005). In vitro generation of infectious scrapie prions. Cell 121, 195-206.
24. Chesebro, B., Trifilo, M., Race, R., Meade-White, K., Teng, C., LaCasse, R., Raymond, L., Favara, C., Baron, G., Priola, S. et al. (2005). Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308, 1435-1439.
25. Cicchetti, F., Saporta, S., Hauser, R. A., Parent, M., Saint-Pierre, M., Sanberg, P. R., Li, X. J., Parker, J. R., Chu, Y., Mufson, E. J. et al. (2009). Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration. Proc. Natl. Acad. Sci. USA 106, 12483-12488.
26. Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A. K., Beibel, M., Staufenbiel, M. et al. (2009). Transmission and spreading of tauopathy in transgenic mouse brain. Nat. Cell Biol. 11, 909-913.
27. Colby, D. W., Giles, K., Legname, G., Wille, H., Baskakov, I. V., Dearmond, S. J. and Prusiner, S. B. (2009). Design and construction of diverse mammalian prion strains. Proc. Natl. Acad. Sci. USA 106, 20417-20422.
28. Cooper, A. A., Gitler, A. D., Cashikar, A., Haynes, C. M., Hill, K. J., Bhullar, B., Liu, K., Xu, K., Strathearn, K. E., Liu, F. et al. (2006). Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 313, 324-328.
29. Crowe, A., Huang, W., Ballatore, C., Johnson, R. L., Hogan, A. M., Huang, R., Wichterman, J., McCoy, J., Huryn, D., Auld, D. S. et al. (2009). Identification of aminothienopyridazine inhibitors of tau assembly by quantitative high-throughput screening. Biochemistry 48, 7732-7745.
30. Crowther, R. A. (1991). Straight and paired helical filaments in Alzheimer disease have a common structural unit. Proc. Natl. Acad. Sci. USA 88, 2288-2292.
31. Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T. and Sulzer, D. (2004). Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305, 1292-1295.
32. +]. Cell 106, 171-182.
33. +] prion in yeast and aggregation of Sup35 in vitro. Proc. Natl. Acad. Sci. USA 101, 12934-12939.
34. Desplats, P., Lee, H. J., Bae, E. J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E. and Lee, S. J. (2009). Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc. Natl. Acad. Sci. USA 106, 13010-13015.
35. DiFiglia, M., Sena-Esteves, M., Chase, K., Sapp, E., Pfister, E., Sass, M., Yoder, J., Reeves, P., Pandey, R. K., Rajeev, K. G. et al. (2007). Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits. Proc. Natl. Acad. Sci. USA 104, 17204-17209.
36. Dobson, C. M. (2003). Protein folding and misfolding. Nature 426, 884-890.
37. Du, Z., Park, K. W., Yu, H., Fan, Q. and Li, L. (2008). Newly identified prion linked to the chromatin-remodeling factor Swi1 in Saccharomyces cerevisiae. Nat. Genet. 40, 460-465.
38. Duyckaerts, C., Delatour, B. and Potier, M. C. (2009). Classification and basic pathology of Alzheimer disease. Acta Neuropathol. 118, 5-36.
39. Edwards, T. L., Scott, W. K., Almonte, C., Burt, A., Powell, E. H., Beecham, G. W., Wang, L., Zuchner, S., Konidari, I., Wang, G. et al. (2010). Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann. Hum. Genet. PMID: 20070850.
40. Eisele, Y. S., Bolmont, T., Heikenwalder, M., Langer, F., Jacobson, L. H., Yan, Z. X., Roth, K., Aguzzi, A., Staufenbiel, M., Walker, L. C. et al. (2009). Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation. Proc. Natl. Acad. Sci. USA 106, 12926-12931.
41. Endoh, R., Ogawara, M., Iwatsubo, T., Nakano, I. and Mori, H. (1993). Lack of the carboxyl terminal sequence of tau in ghost tangles of Alzheimer's disease. Brain Res. 601, 164-172.
42. Farrer, M., Kachergus, J., Forno, L., Lincoln, S., Wang, D. S., Hulihan, M., Maraganore, D., Gwinn-Hardy, K., Wszolek, Z., Dickson, D. et al. (2004). Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann. Neurol. 55, 174-179.
43. Forman, M. S., Trojanowski, J. Q. and Lee, V. M. (2004). Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat. Med. 10, 1055-1063.
44. Frost, B., Jacks, R. L. and Diamond, M. I. (2009a). Propagation of tau misfolding from the outside to the inside of a cell. J. Biol. Chem. 284, 12845-12852.
45. Frost, B., Ollesch, J., Wille, H. and Diamond, M. I. (2009b). Conformational diversity of wild-type Tau fibrils specified by templated conformation change. J. Biol. Chem. 284, 3546-3551.
46. Geser, F., Brandmeir, N. J., Kwong, L. K., Martinez-Lage, M., Elman, L., McCluskey, L., Xie, S. X., Lee, V. M. and Trojanowski, J. Q. (2008). Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch. Neurol. 65, 636-641.
47. Gestwicki, J. E., Crabtree, G. R. and Graef, I. A. (2004). Harnessing chaperones to generate small-molecule inhibitors of amyloid beta aggregation. Science 306, 865-869.
48. Ghaemmaghami, S., Ahn, M., Lessard, P., Giles, K., Legname, G., DeArmond, S. J. and Prusiner, S. B. (2009). Continuous quinacrine treatment results in the formation of drug-resistant prions. PLoS Pathog. 5, e1000673.
49. Giasson, B. I., Forman, M. S., Higuchi, M., Golbe, L. I., Graves, C. L., Kotzbauer, P. T., Trojanowski, J. Q. and Lee, V. M. (2003a). Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 300, 636-640.
50. Giasson, B. I., Lee, V. M. and Trojanowski, J. Q. (2003b). Interactions of amyloidogenic proteins. Neuromolecular Med. 4, 49-58.
51. Gidalevitz, T., Ben-Zvi, A., Ho, K. H., Brignull, H. R. and Morimoto, R. I. (2006). Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science 311, 1471-1474.
52. Gidalevitz, T., Krupinski, T., Garcia, S. and Morimoto, R. I. (2009). Destabilizing protein polymorphisms in the genetic background direct phenotypic expression of mutant SOD1 toxicity. PLoS Genet. 5, e1000399.
53. Gitler, A. D. and Shorter, J. (2007). Prime time for alpha-synuclein. J. Neurosci. 27, 2433-2434.
54. Gitler, A. D., Bevis, B. J., Shorter, J., Strathearn, K. E., Hamamichi, S., Su, L. J., Caldwell, K. A., Caldwell, G. A., Rochet, J. C., McCaffery, J. M. et al. (2008). The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proc. Natl. Acad. Sci. USA 105, 145-150.
55. Gitler, A. D., Chesi, A., Geddie, M. L., Strathearn, K. E., Hamamichi, S., Hill, K. J., Caldwell, K. A., Caldwell, G. A., Cooper, A. A., Rochet, J. C. et al. (2009). Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat. Genet. 41, 308-315.
56. Glenner, G. G. and Wong, C. W. (1984). Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890.
57. Goldgaber, D., Goldfarb, L. G., Brown, P., Asher, D. M., Brown, W. T., Lin, S., Teener, J. W., Feinstone, S. M., Rubenstein, R., Kascsak, R. J. et al. (1989). Mutations in familial Creutzfeldt-Jakob disease and Gerstmann- Straussler-Scheinker's syndrome. Exp. Neurol. 106, 204-206.
58. Gousset, K., Schiff, E., Langevin, C., Marijanovic, Z., Caputo, A., Browman, D. T., Chenouard, N., de Chaumont, F., Martino, A., Enninga, J. et al. (2009). Prions hijack tunnelling nanotubes for intercellular spread. Nat. Cell Biol. 11, 328-336.
59. Hsiao, K., Baker, H. F., Crow, T. J., Poulter, M., Owen, F., Terwilliger, J. D., Westaway, D., Ott, J. and Prusiner, S. B. (1989). Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome. Nature 338, 342-345. (Pubitemid 19082975)
60. Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N. and Ihara, Y. (1994). Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 13, 45-53.
61. Jackson, W. S., Borkowski, A. W., Faas, H., Steele, A. D., King, O. D., Watson, N., Jasanoff, A. and Lindquist, S. (2009). Spontaneous generation of prion infectivity in fatal familial insomnia knockin mice. Neuron 63, 438-450.
62. Johan, K., Westermark, G., Engstrom, U., Gustavsson, A., Hultman, P. and Westermark, P. (1998). Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils. Proc. Natl. Acad. Sci. USA 95, 2558-2563.
63. Johnson, B. S., McCaffery, J. M., Lindquist, S. and Gitler, A. D. (2008). A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Proc. Natl. Acad. Sci. USA 105, 6439-6444.
64. Johnson, B. S., Snead, D., Lee, J. J., McCaffery, J. M., Shorter, J. and Gitler, A. D. (2009). TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J. Biol. Chem. 284, 20329-20339.
65. Kabashi, E., Valdmanis, P. N., Dion, P., Spiegelman, D., McConkey, B. J., Vande Velde, C., Bouchard, J. P., Lacomblez, L., Pochigaeva, K., Salachas, F. et al. (2008). TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 40, 572-574.
66. Kanu, N., Imokawa, Y., Drechsel, D. N., Williamson, R. A., Birkett, C. R., Bostock, C. J. and Brockes, J. P. (2002). Transfer of scrapie prion infectivity by cell contact in culture. Curr. Biol. 12, 523-530.
67. Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W. and Glabe, C. G. (2003). Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489.
68. Keleman, K., Kruttner, S., Alenius, M. and Dickson, B. J. (2007). Function of the Drosophila CPEB protein Orb2 in long-term courtship memory. Nat. Neurosci. 10, 1587-1593.
69. Kerman, A., Liu, H. N., Croul, S., Bilbao, J., Rogaeva, E., Zinman, L., Robertson, J. and Chakrabartty, A. (2010). Amyotrophic lateral sclerosis is a non-amyloid disease in which extensive misfolding of SOD1 is unique to the familial form. Acta Neuropathol. PMID: 20111867.
70. King, C. Y. and Diaz-Avalos, R. (2004). Protein-only transmission of three yeast prion strains. Nature 428, 319-323.
71. Kiskinis, E. and Eggan, K. (2010). Progress toward the clinical application of patient-specific pluripotent stem cells. J. Clin. Invest. 120, 51-59.
72. Knowles, T. P., Fitzpatrick, A. W., Meehan, S., Mott, H. R., Vendruscolo, M., Dobson, C. M. and Welland, M. E. (2007). Role of intermolecular forces in defining material properties of protein nanofibrils. Science 318, 1900-1903.
73. Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B. and Olanow, C. W. (2008). Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat. Med. 14, 504-506.
74. Kotzbauer, P. T., Giasson, B. I., Kravitz, A. V., Golbe, L. I., Mark, M. H., Trojanowski, J. Q. and Lee, V. M. (2004). Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation. Exp. Neurol. 187, 279-288.
75. Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J. T., Schols, L. and Riess, O. (1998). Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18, 106-108.
76. Kwiatkowski, T. J., Jr, Bosco, D. A., Leclerc, A. L., Tamrazian, E., Vanderburg, C. R., Russ, C., Davis, A., Gilchrist, J., Kasarskis, E. J., Munsat, T. et al. (2009). Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205-1208.
77. Kwong, L. K., Uryu, K., Trojanowski, J. Q. and Lee, V. M. (2008). TDP-43 proteinopathies: neurodegenerative protein misfolding diseases without amyloidosis. Neurosignals 16, 41-51.
78. Larsen, K. E., Schmitz, Y., Troyer, M. D., Mosharov, E., Dietrich, P., Quazi, A. Z., Savalle, M., Nemani, V., Chaudhry, F. A., Edwards, R. H. et al. (2006). Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J. Neurosci. 26, 11915-11922.
79. Lashuel, H. A., Hartley, D., Petre, B. M., Walz, T. and Lansbury, P. T., Jr (2002). Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 418, 291.
80. Lauren, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W. and Strittmatter, S. M. (2009). Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457, 1128-1132.
81. Le Pichon, C. E., Valley, M. T., Polymenidou, M., Chesler, A. T., Sagdullaev, B. T., Aguzzi, A. and Firestein, S. (2009). Olfactory behavior and physiology are disrupted in prion protein knockout mice. Nat. Neurosci. 12, 60-69.
82. Lee, H. J., Patel, S. and Lee, S. J. (2005). Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J. Neurosci. 25, 6016-6024.
83. Lee, H. J., Suk, J. E., Bae, E. J., Lee, J. H., Paik, S. R. and Lee, S. J. (2008). Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein. Int. J. Biochem. Cell Biol. 40, 1835-1849.
84. Legname, G., Baskakov, I. V., Nguyen, H. O., Riesner, D., Cohen, F. E., DeArmond, S. J. and Prusiner, S. B. (2004). Synthetic mammalian prions. Science 305, 673-676.
85. Legname, G., Nguyen, H. O., Peretz, D., Cohen, F. E., DeArmond, S. J. and Prusiner, S. B. (2006). Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc. Natl. Acad. Sci. USA 103, 19105-19110.
86. Lesne, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M. and Ashe, K. H. (2006). A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440, 352-357.
87. Li, J. Y., Englund, E., Holton, J. L., Soulet, D., Hagell, P., Lees, A. J., Lashley, T., Quinn, N. P., Rehncrona, S., Bjorklund, A. et al. (2008). Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat. Med. 14, 501-503.
88. Li, J., Browning, S., Mahal, S. P., Oelschlegel, A. M. and Weissmann, C. (2009). Darwinian evolution of prions in cell culture. Science 327, 8869-8872.
89. Li, Y., Ray, P., Rao, E. J., Shi, C., Guo, W., Chen, X., Woodruff, E. A., 3rd, Fushimi, K. and Wu, J. Y. (2010). A Drosophila model for TDP-43 proteinopathy. Proc. Natl. Acad. Sci. USA 107, 3169-3174.
90. Lin, W. L. and Dickson, D. W. (2008). Ultrastructural localization of TDP-43 in filamentous neuronal inclusions in various neurodegenerative diseases. Acta Neuropathol. 116, 205-213.
91. Lo Bianco, C., Shorter, J., Regulier, E., Lashuel, H., Iwatsubo, T., Lindquist, S. and Aebischer, P. (2008). Hsp104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease. J. Clin. Invest. 118, 3087-3097.
92. Luk, K. C., Song, C., O'Brien, P., Stieber, A., Branch, J. R., Brunden, K. R., Trojanowski, J. Q. and Lee, V. M. (2009). Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc. Natl. Acad. Sci. USA 106, 20051-20056.
93. Lundmark, K., Westermark, G. T., Nystrom, S., Murphy, C. L., Solomon, A. and Westermark, P. (2002). Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc. Natl. Acad. Sci. USA 99, 6979-6984.
94. Lundmark, K., Westermark, G. T., Olsen, A. and Westermark, P. (2005). Protein fibrils in nature can enhance amyloid protein A amyloidosis in mice: Cross-seeding as a disease mechanism. Proc. Natl. Acad. Sci. USA 102, 6098-6102.
95. MacDonald, M. E., Ambrose, C. M., Duyao, M. P., Myers, R. H., Lin, C., Srinidhi, L., Barnes, G., Taylor, S. A., James, M., Groot, N. et al. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983.
96. Mallucci, G., Dickinson, A., Linehan, J., Klohn, P. C., Brandner, S. and Collinge, J. (2003). Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302, 871-874.
97. Mallucci, G. R., White, M. D., Farmer, M., Dickinson, A., Khatun, H., Powell, A. D., Brandner, S., Jefferys, J. G. and Collinge, J. (2007). Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron 53, 325-335.
98. Masison, D. C. and Wickner, R. B. (1995). Prion-inducing domain of yeast Ure2p and protease resistance of Ure2p in prion-containing cells. Science 270, 93-95.
99. Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L. and Beyreuther, K. (1985). Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82, 4245-4249.
100. Mathiason, C. K., Powers, J. G., Dahmes, S. J., Osborn, D. A., Miller, K. V., Warren, R. J., Mason, G. L., Hays, S. A., Hayes-Klug, J., Seelig, D. M. et al. (2006). Infectious prions in the saliva and blood of deer with chronic wasting disease. Science 314, 133-136.
101. Mead, S., Whitfield, J., Poulter, M., Shah, P., Uphill, J., Campbell, T., Al-Dujaily, H., Hummerich, H., Beck, J., Mein, C. A. et al. (2009). A novel protective prion protein variant that colocalizes with kuru exposure. N. Engl. J. Med. 361, 2056-2065.
102. Medori, R., Tritschler, H. J., LeBlanc, A., Villare, F., Manetto, V., Chen, H. Y., Xue, R., Leal, S., Montagna, P., Cortelli, P. et al. (1992). Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N. Engl. J. Med. 326, 444-449.
103. Mendez, I., Vinuela, A., Astradsson, A., Mukhida, K., Hallett, P., Robertson, H., Tierney, T., Holness, R., Dagher, A., Trojanowski, J. Q. et al. (2008). Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years. Nat. Med. 14, 507-509.
104. Meyer-Luehmann, M., Coomaraswamy, J., Bolmont, T., Kaeser, S., Schaefer, C., Kilger, E., Neuenschwander, A., Abramowski, D., Frey, P., Jaton, A. L. et al. (2006). Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313, 1781-1784.
105. Meyer-Luehmann, M., Spires-Jones, T. L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., Koenigsknecht-Talboo, J., Holtzman, D. M., Bacskai, B. J. and Hyman, B. T. (2008). Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease. Nature 451, 720-724.
106. Miners, J. S., Baig, S., Palmer, J., Palmer, L. E., Kehoe, P. G. and Love, S. (2008). Abeta-degrading enzymes in Alzheimer's disease. Brain Pathol. 18, 240-252.
107. Mori, F., Tanji, K., Zhang, H. X., Nishihira, Y., Tan, C. F., Takahashi, H. and Wakabayashi, K. (2008). Maturation process of TDP-43-positive neuronal cytoplasmic inclusions in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol. 116, 193-203.
108. Nekooki-Machida, Y., Kurosawa, M., Nukina, N., Ito, K., Oda, T. and Tanaka, M. (2009). Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity. Proc. Natl. Acad. Sci. USA 106, 9679-9684.
109. Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M. et al. (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130-133.
110. Nishihira, Y., Tan, C. F., Onodera, O., Toyoshima, Y., Yamada, M., Morita, T., Nishizawa, M., Kakita, A. and Takahashi, H. (2008). Sporadic amyotrophic lateral sclerosis: two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions. Acta Neuropathol. 116, 169-182.
111. Nonaka, T., Kametani, F., Arai, T., Akiyama, H. and Hasegawa, M. (2009). Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Hum. Mol. Genet. 18, 3353-3364.
112. Oesch, B., Westaway, D., Walchli, M., McKinley, M. P., Kent, S. B., Aebersold, R., Barry, R. A., Tempst, P., Teplow, D. B., Hood, L. E. et al. (1985). A cellular gene encodes scrapie PrP 27-30 protein. Cell 40, 735-746.
113. Pan, K. M., Baldwin, M., Nguyen, J., Gasset, M., Serban, A., Groth, D., Mehlhorn, I., Huang, Z., Fletterick, R. J., Cohen, F. E. et al. (1993). Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. USA 90, 10962-10966.
114. Paravastu, A. K., Qahwash, I., Leapman, R. D., Meredith, S. C. and Tycko, R. (2009). Seeded growth of beta-amyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structure. Proc. Natl. Acad. Sci. USA 106, 7443-7448.
115. +]. J. Mol. Biol. 365, 773-782.
116. Patel, B. K., Gavin-Smyth, J. and Liebman, S. W. (2009). The yeast global transcriptional co-repressor protein Cyc8 can propagate as a prion. Nat. Cell Biol. 11, 344-349.
117. Pesiridis, G. S., Lee, V. M. and Trojanowski, J. Q. (2009). Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis. Hum. Mol. Genet. 18, R156-R162.
118. Petkova, A. T., Leapman, R. D., Guo, Z., Yau, W. M., Mattson, M. P. and Tycko, R. (2005). Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science 307, 262-265.
119. Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R. et al. (1997). Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047.
120. Prilusky, J., Felder, C. E., Zeev-Ben-Mordehai, T., Rydberg, E. H., Man, O., Beckmann, J. S., Silman, I. and Sussman, J. L. (2005). FoldIndex: a simple tool to predict whether a given protein sequence is intrinsically unfolded. Bioinformatics 21, 3435-3438.
121. Prince, M., Jackson, J., Ferri, C. P., Sousa, R., Albanese, E., Ribeiro, W. S. and Honyashiki, M. (2009). Alzheimer's disease international world alzheimer report. In In International AsD (ed), pp. 1-96.
122. Prusiner, S. B. (1982). Novel proteinaceous infectious particles cause scrapie. Science 216, 136-144.
123. Prusiner, S. B. (1998). Prions. Proc. Natl. Acad. Sci. USA 95, 13363-13383.
124. Prusiner, S. B., McKinley, M. P., Bowman, K. A., Bolton, D. C., Bendheim, P. E., Groth, D. F. and Glenner, G. G. (1983). Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35, 349-358.
125. Ramirez, A., Heimbach, A., Grundemann, J., Stiller, B., Hampshire, D., Cid, L. P., Goebel, I., Mubaidin, A. F., Wriekat, A. L., Roeper, J. et al. (2006). Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat. Genet. 38, 1184-1191.
126. Ren, P. H., Lauckner, J. E., Kachirskaia, I., Heuser, J. E., Melki, R. and Kopito, R. R. (2009). Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat. Cell Biol. 11, 219-225.
127. Riemenschneider, M., Klopp, N., Xiang, W., Wagenpfeil, S., Vollmert, C., Muller, U., Forstl, H., Illig, T., Kretzschmar, H. and Kurz, A. (2004). Prion protein codon 129 polymorphism and risk of Alzheimer disease. Neurology 63, 364-366.
128. Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G. Q. and Mucke, L. (2007). Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316, 750-754.
129. Roberts, B. E., Duennwald, M. L., Wang, H., Chung, C., Lopreiato, N. P., Sweeny, E. A., Knight, M. N. and Shorter, J. (2009). A synergistic small-molecule combination directly eradicates diverse prion strain structures. Nat. Chem. Biol. 5, 936-946.
130. Saa, P., Castilla, J. and Soto, C. (2006). Presymptomatic detection of prions in blood. Science 313, 92-94.
131. Safar, J., Wille, H., Itri, V., Groth, D., Serban, H., Torchia, M., Cohen, F. E. and Prusiner, S. B. (1998). Eight prion strains have PrP(Sc) molecules with different conformations. Nat. Med. 4, 1157-1165.
132. Salnikova, A. B., Kryndushkin, D. S., Smirnov, V. N., Kushnirov, V. V. and Ter-Avanesyan, M. D. (2005). Nonsense suppression in yeast cells overproducing Sup35 (eRF3) is caused by its non-heritable amyloids. J. Biol. Chem. 280, 8808-8812.
133. Satake, W., Nakabayashi, Y., Mizuta, I., Hirota, Y., Ito, C., Kubo, M., Kawaguchi, T., Tsunoda, T., Watanabe, M., Takeda, A. et al. (2009). Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat. Genet. 41, 1303-1307.
134. Saupe, S. J. (2007). A short history of small s: a prion of the fungus Podospora anserina. Prion. 1, 110-115.
135. Sawaya, M. R., Sambashivan, S., Nelson, R., Ivanova, M. I., Sievers, S. A., Apostol, M. I., Thompson, M. J., Balbirnie, M., Wiltzius, J. J., McFarlane, H. T. et al. (2007). Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature 447, 453-457.
136. Scherzinger, E., Lurz, R., Turmaine, M., Mangiarini, L., Hollenbach, B., Hasenbank, R., Bates, G. P., Davies, S. W., Lehrach, H. and Wanker, E. E. (1997). Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90, 549-558.
137. Shorter, J. (2008). Hsp104: a weapon to combat diverse neurodegenerative disorders. Neurosignals 16, 63-74.
138. Shorter, J. and Lindquist, S. (2004). Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers. Science 304, 1793-1797.
139. Shorter, J. and Lindquist, S. (2005). Prions as adaptive conduits of memory and inheritance. Nat. Rev. Genet. 6, 435-450.
140. Shorter, J. and Lindquist, S. (2006). Destruction or potentiation of different prions catalyzed by similar Hsp104 remodeling activities. Mol. Cell 23, 425-438.
141. Si, K., Lindquist, S. and Kandel, E. R. (2003). A neuronal isoform of the Aplysia CPEB has prion-like properties. Cell 115, 879-891.
142. Si, K., Choi, Y. B., White-Grindley, E., Majumdar, A. and Kandel, E. R. (2010). Aplysia CPEB can form prion-like multimers in sensory neurons that contribute to long-term facilitation. Cell 140, 421-435.
143. Simon-Sanchez, J., Schulte, C., Bras, J. M., Sharma, M., Gibbs, J. R., Berg, D., Paisan-Ruiz, C., Lichtner, P., Scholz, S. W., Hernandez, D. G. et al. (2009). Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet. 41, 1308-1312.
144. Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R. et al. (2003). alpha-Synuclein locus triplication causes Parkinson's disease. Science 302, 841.
145. Skovronsky, D. M., Lee, V. M. and Trojanowski, J. Q. (2006). Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Annu. Rev. Pathol. 1, 151-170.
146. Smith, J. F., Knowles, T. P., Dobson, C. M., Macphee, C. E. and Welland, M. E. (2006). Characterization of the nanoscale properties of individual amyloid fibrils. Proc. Natl. Acad. Sci. USA 103, 15806-15811.
147. Soldner, F., Hockemeyer, D., Beard, C., Gao, Q., Bell, G. W., Cook, E. G., Hargus, G., Blak, A., Cooper, O., Mitalipova, M. et al. (2009). Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136, 964-977.
148. Solomon, A., Richey, T., Murphy, C. L., Weiss, D. T., Wall, J. S., Westermark, G. T. and Westermark, P. (2007). Amyloidogenic potential of foie gras. Proc. Natl. Acad. Sci. USA 104, 10998-11001.
149. Soper, J. H., Roy, S., Stieber, A., Lee, E., Wilson, R. B., Trojanowski, J. Q., Burd, C. G. and Lee, V. M. (2008). Alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae. Mol. Biol. Cell 19, 1093-1103.
150. Soto, C. (2003). Unfolding the role of protein misfolding in neurodegenerative diseases. Nat. Rev. Neurosci. 4, 49-60.
151. Soto, C. and Castilla, J. (2004). The controversial protein-only hypothesis of prion propagation. Nat. Med. 10, S63-S67.
152. Speare, J. O., Offerdahl, D. K., Hasenkrug, A., Carmody, A. B. and Baron, G. S. (2009). GPI anchoring facilitates propagation and spread of misfolded Sup35 aggregates in mammalian cells. EMBO J. 29, 782-794.
153. Sponarova, J., Nystrom, S. N. and Westermark, G. T. (2008). AA-amyloidosis can be transferred by peripheral blood monocytes. PLoS One 3, e3308.
154. Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E. et al. (2008). TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668-1672.
155. Steele, A. D., Lindquist, S. and Aguzzi, A. (2007). The prion protein knockout mouse: a phenotype under challenge. Prion 1, 83-93.
156. Steele, A. D., Zhou, Z., Jackson, W. S., Zhu, C., Auluck, P., Moskowitz, M. A., Chesselet, M. F. and Lindquist, S. (2009). Context dependent neuroprotective properties of prion protein (PrP). Prion 3, 240-249.
157. Tamguney, G., Miller, M. W., Wolfe, L. L., Sirochman, T. M., Glidden, D. V., Palmer, C., Lemus, A., DeArmond, S. J. and Prusiner, S. B. (2009). Asymptomatic deer excrete infectious prions in faeces. Nature 461, 529-532.
158. Tanaka, M., Chien, P., Naber, N., Cooke, R. and Weissman, J. S. (2004). Conformational variations in an infectious protein determine prion strain differences. Nature 428, 323-328.
159. Tanaka, M., Collins, S. R., Toyama, B. H. and Weissman, J. S. (2006). The physical basis of how prion conformations determine strain phenotypes. Nature 442, 585-589.
160. Toombs, J. A., McCarty, B. R. and Ross, E. D. (2010). Compositional Determinants of Prion Formation in Yeast. Mol. Cell. Biol. 30, 319-332.
161. True, H. L. and Lindquist, S. L. (2000). A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature 407, 477-483.
162. Tyedmers, J., Madariaga, M. L. and Lindquist, S. (2008). Prion switching in response to environmental stress. PLoS Biol. 6, e294.
163. Van Deerlin, V. M., Leverenz, J. B., Bekris, L. M., Bird, T. D., Yuan, W., Elman, L. B., Clay, D., Wood, E. M., Chen-Plotkin, A. S., Martinez-Lage, M. et al. (2008). TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 7, 409-416.
164. Vance, C., Rogelj, B., Hortobagyi, T., De Vos, K. J., Nishimura, A. L., Sreedharan, J., Hu, X., Smith, B., Ruddy, D., Wright, P. et al. (2009). Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208-1211.
165. Vashist, S., Cushman, M. and Shorter, J. (2010). Applying Hsp104 to protein-misfolding disorders. Biochem. Cell Biol. 88, 1-13.
166. Vitrenko, Y. A., Gracheva, E. O., Richmond, J. E. and Liebman, S. W. (2007). Visualization of aggregation of the Rnq1 prion domain and cross-seeding interactions with Sup35NM. J. Biol. Chem. 282, 1779-1787.
167. Walker, F. O. (2007). Huntington's disease. Lancet 369, 218-228.
168. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J. and Selkoe, D. J. (2002). Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539.
169. Wang, F., Wang, X., Yuan, C. G. and Ma, J. (2010). Generating a prion with bacterially expressed recombinant prion protein. Science 327, 1132-1135.
170. Wang, H., Duennwald, M. L., Roberts, B. E., Rozeboom, L. M., Zhang, Y. L., Steele, A. D., Krishnan, R., Su, L. J., Griffin, D., Mukhopadhyay, S. et al. (2008). Direct and selective elimination of specific prions and amyloids by 4,5-dianilinophthalimide and analogs. Proc. Natl. Acad. Sci. USA 105, 7159-7164.
171. Warrick, J. M., Chan, H. Y., Gray-Board, G. L., Chai, Y., Paulson, H. L. and Bonini, N. M. (1999). Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat. Genet. 23, 425-428.
172. Wegorzewska, I., Bell, S., Cairns, N. J., Miller, T. M. and Baloh, R. H. (2009). TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. USA 106, 18809-18814.
173. Wernig, M., Zhao, J. P., Pruszak, J., Hedlund, E., Fu, D., Soldner, F., Broccoli, V., Constantine-Paton, M., Isacson, O. and Jaenisch, R. (2008). Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl. Acad. Sci. USA 105, 5856-5861.
174. Westermark, G. T. and Westermark, P. (2009). Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis. FEBS Lett. 583, 2685-2690.
175. Wiltzius, J. J., Landau, M., Nelson, R., Sawaya, M. R., Apostol, M. I., Goldschmidt, L., Soriaga, A. B., Cascio, D., Rajashankar, K. and Eisenberg, D. (2009). Molecular mechanisms for protein-encoded inheritance. Nat. Struct. Mol. Biol. 16, 973-978.
176. Yamamoto, A., Lucas, J. J. and Hen, R. (2000). Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 101, 57-66.
177. Yamanaka, S. (2007). Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 1, 39-49.
178. Zarranz, J. J., Alegre, J., Gomez-Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atares, B. et al. (2004). The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55, 164-173.
179. Zhang, B., Une, Y., Fu, X., Yan, J., Ge, F., Yao, J., Sawashita, J., Mori, M., Tomozawa, H., Kametani, F. et al. (2008). Fecal transmission of AA amyloidosis in the cheetah contributes to high incidence of disease. Proc. Natl. Acad. Sci. USA 105, 7263-7268.
180. Zhang, Y. J., Xu, Y. F., Cook, C., Gendron, T. F., Roettges, P., Link, C. D., Lin, W. L., Tong, J., Castanedes-Casey, M., Ash, P. et al. (2009). Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc. Natl. Acad. Sci. USA 106, 7607-7612.